Navigation Links
ACO Proposed Rule: Nine out of Ten Quality Measures Mirror Other Quality Reporting Programs
Date:4/4/2011

EMERYVILLE, Calif., April 4, 2011 /PRNewswire/ -- Newly proposed Medicare rules designed to promote and reward high-quality patient care under healthcare reform closely mirror quality reporting programs already well established as part of the American healthcare system, a MedeAnalytics analysis has found.

(Logo:  http://photos.prnewswire.com/prnh/20100621/SF23660LOGO)

The quality measure analysis is included in MedeAnalytics' white paper, "Accountable Care Organizations: Summary and Analysis of the Proposed Rule," available at the company's Accountable Care Organization (ACO) Resource Center. MedeAnalytics is a healthcare performance management firm that collects and analyzes data to help hospitals, physician practices and payers ensure accountability and improve financial, operational and clinical outcomes, a key element of successfully managing ACOs.

The proposed rule issued by the Department of Health and Human Services on March 31, 2011 specifies 65 quality measures, of which 58 overlap with one or more other quality reporting programs, MedeAnalytics found. The other quality measurement programs include the Agency for Healthcare Research and Quality (AHRQ) Prevention Quality Indicators and Patient Safety Indicators, the Healthcare Effectiveness and Data Information Set (HEDIS), Meaningful Use Stage 2, the Physician Quality Reporting System (PQRS), and the Value-Based Purchasing (VBP) program.

"The high degree of commonality for quality measures should help ACOs meet the Shared Savings Program's year 1 quality performance standards, since healthcare providers are quite familiar with their nature, required data collection methods and reporting processes," commented Mino Sastry, MPH, a product marketing manager for MedeAnalytics' provider solutions.  

About ACOsWhile the ACO label has been around since 2006, it was mentioned in numerous healthcare reform bills proposed in 2009 and was ultimately included in Section 3022 of the Patient Protection and Affordable Care Act (ACA) as the Medicare Shared Savings Program. The ACA's ACO provision covers Medicare ACOs. The Shared Savings Program is a new approach to the delivery of healthcare aimed at: (1) better care for individuals; (2) better health for populations; and (3) lower growth in expenditures.

About MedeAnalyticsFounded in 1994, MedeAnalytics delivers performance management solutions across the healthcare system—including hospitals, physician practices and payers—to ensure accountability and improve financial, operational and clinical outcomes. For more information, visit www.medeanalytics.com.For more information:

MedeAnalytics, Inc.Bruce Lewis

5858 Horton Street, Suite 475 Lewis & Summers Public Relations

Emeryville, CA  94608 (707) 813-1197bruce@prwebsite.com
'/>"/>

SOURCE MedeAnalytics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ACO Proposed Rule: Over 90 Percent of Commercial Payer RFI Suggestions Incorporated
2. ACO Proposed Rule Simplified: MedeAnalytics Releases Comprehensive White Paper
3. Palatin Technologies, Inc. Announces Proposed Public Offering of Common Stock and Warrants
4. Amarin Announces Proposed Public Offering of American Depositary Shares
5. AVANIR Pharmaceuticals Announces Proposed Public Offering of Common Stock
6. PharmAthene Announces Proposed Common Stock Offering
7. OncoGenex Pharmaceuticals, Inc. Announces Proposed Public Offering
8. Mylan Announces Proposed Add-On Private Placement of its Senior Notes Due 2020
9. Complaint Filed Regarding Proposed Merger
10. InterMune Announces Proposed Public Offering of Common Stock
11. Dendreon Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Cambridge, MA (PRWEB) , ... January 20, 2017 ... ... and scientific consulting and resource to the healthcare industry ( http://www.gandlscientific.com ), has ... to its expanding team of clinical and scientific consultants and contractors. This is ...
(Date:1/21/2017)... , Jan. 20, 2017 Interpace ... a company that provides clinically useful molecular diagnostic ... has entered into a securities purchase agreement with ... 855,000 shares of common stock in a registered ... Company has agreed to sell to the same ...
(Date:1/21/2017)... , Jan. 21, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, today presented ... compound, napabucasin, at the 2017 American Society of Clinical ... Francisco . In a Phase ... agent designed to inhibit cancer stemness pathways by targeting ...
(Date:1/20/2017)... 20, 2017 Ginkgo Bioworks, the organism ... pioneer in the synthesis and assembly of DNA. ... assembling pathway-length synthetic DNA into Ginkgo,s automated organism ... the construction of new organism designs for application ... "Gen9 was founded to significantly increase the world,s ...
Breaking Biology Technology:
(Date:1/6/2017)... JOLLA, Calif. , Jan. 6, 2017 /PRNewswire/ ... 1 safety studies in healthy volunteers of a ... intended to treat acute pancreatitis. ... is typically a mild disorder, but can be ... organ failure and sepsis, where extended hospital stays, ...
(Date:1/3/2017)... 3, 2017 Onitor, provider of digital health ... Track, an innovative biometric data-driven program designed to aid ... at the 2017 Consumer Electronics Show (CES) in ... the U.S., the World Health Organization (WHO), have identified ... adults who are overweight or obese. WHO also states ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
Breaking Biology News(10 mins):